Pham Quang X sold 1,165 shares of Cadrenal Therapeutics, Inc. at $5.69 for −$6.63k on May 22, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
CEO and Chairman
CEO and Chairman
Filed May 26, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$6,628.85Shares × reported price
Shares traded
1,165Common Stock
Price per share
$5.69Reported price. Read footnotes for ranges.
% of reported position traded
0.59%This security and ownership context
Holdings after
194,924Direct
Trade date
May 22, 2026Sell
Filed
May 26, 2026, 9:06 PM ET5-day reporting delay
Accession
0001213900-26-061167Code S · Transaction 385502
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 196,089 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

CVKD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CVKD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +19%1w ago +2.8%1d ago +5.1%
Returns since7d −15%30d −38%90d −69%180d1y

Footnotes in full

F1: Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.60 through $5.82. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: Quang Pham is the Trustee of The PVBQ Living Trust and has sole voting and dispositive power with respect to the shares owned by The PVBQ Trust, of which Mr. Pham's child is the sole beneficiary.